Skip to main content

Table 2 Summary of study outcomes

From: Effectiveness of pharmacist home visits for individuals at risk of medication-related problems: a systematic review and meta-analysis of randomised controlled trials

Study

Number

Reported outcome measures

Results:

Pharmacist home visit group compared to control

Begley 1995 [35] & Begley 1997 [23]

n = 222

Medication adherence at 12/12

Contact with GPs from 3/12 to 12/12

Hoarding at 3/12

Economic evaluation

Improved: 86% vs 69%, p = 0.0001

Less: 54% vs 74%, p < 0.01

Less: 1% vs > 95%, P < 0.001

Cost effective (net benefit of the 1st visit £864.47 dropping to £4.87 at the 5th visit)

Holland 2005 [24] & Pacini 2007 [5]

n = 822

Emergency hospital readmission over 6/12

Death within 6/12

Admission to care home over 6/12

QOL EQ. 5D change over 6/12

QOL VAHS change over 6/12

Hoarding

Economic evaluation

RR 1.30, 95%CI (1.07 to 1.58), p = 0.0009

HR 0.75 (0.53 to 1.10), p = 0.14

37/300 vs 32/285, NS

0.006 (− 0.048 to 0.059), p = 0.84

Worse: −4.12 (−8.09 to − 0.15), p = 0.042

Decreased in INT: 40 to 19%, p < 0.001

Not cost effective (net increase of £271 for NHS per patient)

Holland 2007 [25]

n = 339

Emergency hospital readmission over 6/12

Death within 6/12

QOL EQ. 5D change over 6/12

QOL VAHS change over 6/12

Medication adherence (MARS) at 6/12

RR 1.15 (1.08 to 1.40), p = 0.59

HR 1.18 (0.69 to 2.03), p = 0.54

0.07 (− 0.01 to 0.14), p = 0.08

− 0.93 (− 6.05 to 4.20), p = 0.72

0.12 (− 48 to 0.73)p = 0.68

Jackson 2004 [28]

n = 128

Bleeding complications over 3/12

Readmission due to bleeding over 3/12

Death within 3/12

15% vs 36%, p = 0.009

3% vs 8%, p = 0.32

7% vs 8%, p = 0.90

Lenaghan 2007 [33]

n = 136

Non elective hospital admissions over 6/12

Death within 6/12 (% diff in proportion)

Admission to care home over 6/12 (% diff in proportion)

QOL EQ. 5D change over 6/12

QOL VAHS change over 6/12

RR 0.92 (0.50 to 1.70), p = 0.80

1.3% (− 12.2 to 14.7), p = 0.81

− 3.0% (− 11.0 to 5.0), p = 0.30

0.09 (− 0.19 to 0.02), p = 0.10

4.8 (− 12.5 to 2.8), p = 0.21

Naunton 2003 [32]

n = 136

Unplanned hospital admissions at 3/12

Death within 3/12

Medication adherence (“never miss”)

28% vs 45%, p = 0.05

5% vs 8%, not reported

87% vs 44%, p < 0.001

Olesen 2014 [26]

n = 630

Non elective hospital admissions over 24/12

Death within 24/12

Medication adherence (% non-adherent)

OR 1.14 (0.78 to 1.67), NS

HR 1.41 (0.71 to 2.82), NS

11% vs 10%, NS

Peterson 2004 [29]

n = 94

Medication adherence (never/rarely miss) Cholesterol levels

NS difference

4.4 (0.6) vs 4.6 (0.8) mmol/L, p = 0.24

Sidel 1990 [22]

n = 284

Medication adherence (change in those who ‘remember to take’)

Health service contact (change in 3/12)

−.09 vs − 0.19, p = 0.52

− 1.16 vs 0.25, p = 0.08

Triller 2007 [30]

n = 144

All cause hospital admissions,

HF- related admissions

Death

QOL (not named)

Care costs

58% vs 55%, p = 0.63

51% vs 42%, p = 0.26

18% vs 22%, p = 0.67

NS difference

NS difference

Tuttle 2018 [31]

n = 159

Acute care utilisation (hospital admissions, emergency care visits, urgent care centre visits)

NS difference: 44% vs 41%, p = 0.72

(hospital admissions 26% vs 26%, p = 0.95)

Vuong 2008 [27]

n = 316

Medication adherence (modified Morisky)

Medication knowledge (bespoke)

Improved: 0.23 vs 0.41, p = 0.028

Improved: 0.70 (0.24) vs 0.78 (0.14), p = 0.001

  1. Key: QOL Quality of Life, RR Rate ratio, OR Odds ratio, HR Hazard ratio, NS Not significant, HF Heart failure